CEO of Natera Inc (NTRA, Financial) Matthew Rabinowitz sold 212,001 shares of NTRA on 09/21/2018 at an average price of $23.88 a share. The total sale was $5.1 million.
Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity. Natera Inc has a market cap of $1.47 billion; its shares were traded at around $24.05 with and P/S ratio of 5.50.
CEO Recent Trades:
- CEO Matthew Rabinowitz sold 212,001 shares of NTRA stock on 09/21/2018 at the average price of $23.88. The price of the stock has increased by 0.71% since.
- CEO Matthew Rabinowitz sold 251,699 shares of NTRA stock on 09/18/2018 at the average price of $24.17. The price of the stock has decreased by 0.5% since.
- CEO Matthew Rabinowitz sold 403,462 shares of NTRA stock on 09/13/2018 at the average price of $24.9. The price of the stock has decreased by 3.41% since.
CFO Recent Trades:
- CFO Michael Burkes Brophy sold 108,108 shares of NTRA stock on 09/14/2018 at the average price of $24.31. The price of the stock has decreased by 1.07% since.
Directors and Officers Recent Trades:
- COO Steven Leonard Chapman sold 35,000 shares of NTRA stock on 09/19/2018 at the average price of $23.81. The price of the stock has increased by 1.01% since.
- Chief Technology Officer Jonathan Sheena sold 166,667 shares of NTRA stock on 09/14/2018 at the average price of $24.27. The price of the stock has decreased by 0.91% since.
- COO Steven Leonard Chapman sold 45,000 shares of NTRA stock on 09/11/2018 at the average price of $25.16. The price of the stock has decreased by 4.41% since.
For the complete insider trading history of NTRA, click here
.
